NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia

Journal of Cerebral Blood Flow and Metabolism

Volumn 20, Issue 5, 2000, Pages 772-779

  Yam, Philippa S ^a   Dunn, Laurence T ^a   Graham, David I ^a   Dewar, Deborah ^a   McCulloch, James ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Ischemia; Middle cerebral artery occlusion; NMDA antagonists; White matter

Indexed keywords

AMYLOID PRECURSOR PROTEIN; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CAT; CONTROLLED STUDY; DRUG EFFICACY; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; STROKE;

EID: 0034067127     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200005000-00003     Document Type: Article

References (11)

1. Adams JH, Doyle D, Ford I, Graham DI, McLellan D (1989) Diffuse axonal injury in head injury; definition, diagnosis and grading. Histopathology 15:49-59
2. Blumbergs PC, Scott G, Manavis J, et al (1994) Staining of amyloid precursor protein to study axonal damage in mild head injury. Lancet 344:1055-1056
3. Brierley JB, Graham DI (1984) Hypoxia and vascular disorders of the central nervous system. In: Greenfield's neuropathology (Adams JH, Corsellis JAN, Duchen LW, eds), London, Edward Arnold, pp 125-207
4. Brown AW, Brierley JB (1968) The nature, distribution and earliest stages of anoxic-ischemic nerve cell damage in the rat brain as defined by the optical microscope. Br J Exp Pathol 49:87-106
5. Bullock R (1998) Strategies for neuroprotection with glutamate antagonists. In: Neuroprotective agents: clinical and experimental aspects (Boland B, Cullinan J, Kimball C, eds), New York, New York Academy of Sciences, pp 272-278
6. Dewar D, Dawson DA (1995) Tau protein is altered by focal cerebral ischemia in the rat: an immunohistochemical and immunoblotting study. Brain Res 684:70-78
7. Suenaga T, Ohnishi K, Nishimura M, et al (1994) Bundles of amyloid precursor protein-immunoreactive axons in human cerebrovascular white matter lesions. Acta Neuropathol Berl 87:450-455
8. Uematsu D, Araki N, Greenberg JH, Sladky J, Reivich M (1991) Combined therapy with MK-801 and nimodipine for protection of ischemic brain damage. Neurology 41:88-94
9. Valeriani V, Dewar D, McCulloch J (2000) Quantitative assessment of ischemic pathology in axons, oligodendrocytes and neurons: attenuation of damage after transient ischemia. J Cereb Blood Flow Metab 20:765-771
10. Wahlgren NG (1997) A review of earlier clinical studies on neuroprotective agents and current approaches. In: Neuroprotective agents and cerebral ischemia (Green AR, and Cross AJ, eds). Academic Press Ltd, pp 337-363
11. Waxman SG, Black JA, Stys PK, Ransom BR (1992) Ultrastructural concomitants of anoxic injury and early post-anoxic recovery in rat optic nerve. Brain Res 574:105-119